P. Krespi

493 total citations
16 papers, 401 citations indexed

About

P. Krespi is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, P. Krespi has authored 16 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Epidemiology. Recurrent topics in P. Krespi's work include Blood Pressure and Hypertension Studies (7 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Hormonal Regulation and Hypertension (3 papers). P. Krespi is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Hormonal Regulation and Hypertension (3 papers). P. Krespi collaborates with scholars based in Greece and United States. P. Krespi's co-authors include A. Hatzizacharias, Michael Kyriakidis, Thomas Makris, V. Votteas, Filippos Triposkiadis, George Stavroulakis, Argyri Gialeraki, T. Makris, Maria V. Poulakou and Dimitrios Papadopoulos and has published in prestigious journals such as American Heart Journal, American Journal of Hypertension and International Journal of Cardiology.

In The Last Decade

P. Krespi

16 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Krespi Greece	10	245	101	83	58	50	16	401
A. Hatzizacharias Greece	10	216 0.9×	100 1.0×	83 1.0×	59 1.0×	52 1.0×	16	373
Giovanni Cerasola Italy	15	370 1.5×	191 1.9×	95 1.1×	72 1.2×	15 0.3×	32	739
Pierangelo Lazzari Italy	16	498 2.0×	288 2.9×	67 0.8×	66 1.1×	27 0.5×	28	681
Velia Cassano Italy	14	202 0.8×	89 0.9×	50 0.6×	101 1.7×	30 0.6×	50	464
Anna Vadalà Italy	14	240 1.0×	45 0.4×	64 0.8×	80 1.4×	13 0.3×	17	478
Sona Haku Japan	13	182 0.7×	101 1.0×	48 0.6×	59 1.0×	18 0.4×	25	366
Ryu Kobayashi Japan	15	227 0.9×	162 1.6×	66 0.8×	72 1.2×	19 0.4×	42	521
Ch. Schnack Austria	14	200 0.8×	154 1.5×	52 0.6×	65 1.1×	12 0.2×	20	500
F CUCCURULLO Italy	7	403 1.6×	135 1.3×	39 0.5×	51 0.9×	16 0.3×	8	540
Tomohiko Kanaoka Japan	17	345 1.4×	226 2.2×	68 0.8×	88 1.5×	19 0.4×	51	706

Countries citing papers authored by P. Krespi

Since Specialization

Citations

This map shows the geographic impact of P. Krespi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Krespi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Krespi more than expected).

Fields of papers citing papers by P. Krespi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Krespi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Krespi. The network helps show where P. Krespi may publish in the future.

Co-authorship network of co-authors of P. Krespi

This figure shows the co-authorship network connecting the top 25 collaborators of P. Krespi. A scholar is included among the top collaborators of P. Krespi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Krespi. P. Krespi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Papadopoulos, Dimitrios, et al.. (2006). Antiendothelial Cell Antibody Levels in Healthy Normotensives with High Normal Blood Pressure. Clinical and Experimental Hypertension. 28(8). 663–667. 8 indexed citations

Makris, Thomas, et al.. (2006). White coat hypertension and haemostatic/fibrinolytic balance disorders.. PubMed. 17(2). 137–41. 7 indexed citations

Papadopoulos, Dimitrios, Thomas Makris, P. Krespi, et al.. (2005). Adiponectin and Resistin Plasma Levels in Healthy Individuals With Prehypertension. Journal of Clinical Hypertension. 7(12). 729–733. 33 indexed citations

Papadopoulos, Dimitris, P. Krespi, Maria V. Poulakou, et al.. (2005). Human Soluble Leptin Receptor Number in Healthy Normotensive Individuals With High Normal Blood Pressure. American Journal of Hypertension. 18(7). 1001–1004. 8 indexed citations

Papadopoulos, Dimitrios, Thomas Makris, P. Krespi, et al.. (2005). Changes in metalloproteinases in healthy normotensive patients with high-normal blood pressure.. PubMed. 16(3). 211–4. 9 indexed citations

Paizis, Ioannis, P. Krespi, Ourania Papazachou, et al.. (2004). Insulin receptor number is reduced in healthy offspring of patients with essential hypertension. American Journal of Hypertension. 17(10). 911–914. 6 indexed citations

Krespi, P., et al.. (2004). Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.. PubMed. 30(3). 125–32. 21 indexed citations

Makris, Thomas, et al.. (2003). Markers of risk in young offspring with paternal history of myocardial infarction. International Journal of Cardiology. 89(2-3). 287–293. 12 indexed citations

Makris, Thomas, George Stavroulakis, A. Hatzizacharias, et al.. (2003). Parental history of hypertension is associated with coagulation–fibrinolytic balance disorders. Thrombosis Research. 111(1-2). 45–49. 7 indexed citations

10.

Stavroulakis, George, Thomas Makris, P. Krespi, et al.. (2000). Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism. Cardiovascular Drugs and Therapy. 14(4). 427–432. 65 indexed citations

11.

Makris, T., P. Krespi, A. Hatzizacharias, et al.. (2000). Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol. American Journal of Hypertension. 13(7). 783–788. 71 indexed citations

12.

Makris, Thomas, George Stavroulakis, Urania Dafni, et al.. (2000). ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. American Heart Journal. 140(5). 760–765. 22 indexed citations

13.

Makris, Thomas, George Stavroulakis, P. Krespi, et al.. (1999). Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension. American Heart Journal. 138(5). 922–925. 32 indexed citations

14.

Makris, Thomas, et al.. (1999). Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. American Heart Journal. 138(2). 241–246. 32 indexed citations

15.

Krespi, P., et al.. (1998). Moxonidine Effect on Microalbuminuria, Thrombomodulin, and Plasminogen Activator Inhibitor-1 Levels in Patients with Essential Hypertension. Cardiovascular Drugs and Therapy. 12(5). 463–467. 37 indexed citations

16.

Makris, Thomas, P. Krespi, A. Hatzizacharias, et al.. (1997). HAEMOSTASIS BALANCE DISORDERS IN PATIENTS WITH ESSENTIAL HYPERTENSION. Thrombosis Research. 88(2). 99–107. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact